Setipiprant

DB12562InvestigationalSmall molecule

Setipiprant has been investigated for the treatment of Seasonal Allergic Rhinitis, asthma and scalp hair loss (Androgenetic Alopecia).

Chemical structure of Setipiprant
Mechanism
Curator reviewed
Formula / weight
C24H19FN2O3 · 402.425 g/mol (avg)
Code names
ACT-129968 · KYTH-105

Resolves to

Compound
UNIIBHF20LA2GMCAS866460-33-5ChEMBLCHEMBL2386081ChEBI177430PubChem49843471
Structure
InChIKeyIHAXLPDVOWLUOS-UHFFFAOYSA-NSMILESOC(=O)CN1C2=C(CN(CC2)C(=O)C2=CC=CC3=CC=CC=C23)C2=CC(F)=CC=C12
Targets
Q9Y5Y4PTGDR2Q13258PTGDR

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Setipiprant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In